tiprankstipranks
Advertisement
Advertisement
Medline Stock (MDLN) Rises despite FDA Controversy — Here’s Why
PremiumMarket NewsMedline Stock (MDLN) Rises despite FDA Controversy — Here’s Why
5d ago
Johnson & Johnson presents exploratory analyses from DAHLIAS study
Premium
The Fly
Johnson & Johnson presents exploratory analyses from DAHLIAS study
5d ago
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study
Premium
The Fly
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study
5d ago
Best ETFs to Invest In, According to AI Analyst, 5/29/2026
PremiumMarket NewsBest ETFs to Invest In, According to AI Analyst, 5/29/2026
9d ago
J&J reports updated results from Phase 1/1b CHRYSALIS-2 study
Premium
The Fly
J&J reports updated results from Phase 1/1b CHRYSALIS-2 study
9d ago
Johnson & Johnson reports new data from Phase 3 MajesTEC-9 study
Premium
The Fly
Johnson & Johnson reports new data from Phase 3 MajesTEC-9 study
10d ago
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
PremiumThe FlyTrump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
21d ago
Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts
Premium
Analysts
Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts
23d ago
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
Premium
The Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100